This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Applying to Renovatio Clinical · The Woodlands, Texas
Answer a few short questions to share with the research team.